Discussions on VT4COVID
- PMID: 37914470
- DOI: 10.1016/S2213-2600(23)00343-0
Discussions on VT4COVID
Conflict of interest statement
CB receives consulting fees from Sedana Medical. KK receives lecture fees from Fresenius Kabi and Sedana Medical and receives advisory board fees from Viatris. CB and EWE receive financial support from the US National Institutes of Health (1R42AG080892–01).
Comment in
-
Discussions on VT4COVID - Authors' reply.Lancet Respir Med. 2023 Nov;11(11):e91-e92. doi: 10.1016/S2213-2600(23)00344-2. Lancet Respir Med. 2023. PMID: 37914472 No abstract available.
Comment on
-
Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial.Lancet Respir Med. 2023 Nov;11(11):991-1002. doi: 10.1016/S2213-2600(23)00221-7. Epub 2023 Jul 12. Lancet Respir Med. 2023. PMID: 37453445 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources